From Hot Flashes To Breast Cancer
Hormone balance vs. hormone replacement is the hot topic among those who believe breast cancer can be prevented and menopause symptoms treated safely without the use of synthetic, potentially carcinogenic hormones.
According to Oregon biochemist and cancer researcher, David Zava, PH.D., nearly all risk factors associated with breast cancer stem from excess estrogens and related hormonal imbalances. A growing body of research leading to that conclusion has thousands of health care practitioners around the country re-thinking their approach to hormone-related health issues. Zava, the co-author of What Your Doctor May Not Tell You About Breast Cancer: How Hormone Balance Can Help Save Your Life, established ZRT Laboratory ten years ago to make hormone testing more widely-available to physicians and their patients. ZRT leads the industry in research and education with over a million hormone test results in its database.
A variety of natural (bio-identical) hormone therapy options are available and tracking hormonal changes through saliva and blood spot testing helps physicians tailor treatments to each individual. In addition, ZRT's at-home test kits are minimally-invasive, facilitate self-sampling at the optimal time, and are less stressful and costly than routinely-used blood tests. Proponents of the testing find that it is far more representative of active, "bio-available" hormone levels, and more in-sync with symptoms like low libido, hot flashes, irritability, fatigue, headaches and thyroid issues.
Once specific hormone levels are determined, appropriate, individualized hormone balancing can begin. After the large, federal Women's Health Initiative study was cut short in 2002 when stunned doctors and patients saw that conventional Hormone Replacement Therapy (HRT) increased the risk of heart attack, strokes and breast cancer, millions of women took the news to heart and stopped taking the drugs. And a study in the New England Journal of Medicine (4/19/07) recently revealed that after the sharp decline in use of HRT, breast cancer rates also declined.
Today, twenty million American women between the ages of 45 and 54 are more than ever before, seeking safe solutions for hormone-related health issues that won't raise their risks for breast cancer. With the help of hormone testing, their options just got better.